Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Provided By GlobeNewswire
Last update: Nov 20, 2025
NESS ZIONA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced financial results for the third quarter ending September 30, 2025, and provided a corporate update.
Read more at globenewswire.com
